Is CNDCF or MRK a better dividend investment in 2026?

CNDCF currently yields 12.97% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: CNDCF offers higher current income.

What is the dividend yield difference between CNDCF and MRK?

CNDCF has a forward dividend yield of 12.97% ($1.25/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 9.72 percentage points.

Home › Compare › CNDCF vs MRK

CNDCF vs MRK: Dividend Comparison 2026

CNDCF yields 12.97% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CNDCF wins by $2566388.60M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CNDCF

● Live price

12.97%

Share price

$9.60

Annual div

$1.25

5Y div CAGR

100%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$2566388.63M

Annual income

$2,528,927,909,631.32

Full CNDCF calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — CNDCF vs MRK

📍 CNDCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CNDCF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CNDCF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CNDCF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CNDCF

Annual income on $10K today (after 15% tax)

$1,102.34/yr

After 10yr DRIP, annual income (after tax)

$2,149,588,723,186.62/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, CNDCF beats the other by $2,149,588,722,378.88/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CNDCF + MRK for your $10,000?

CNDCF: 50%MRK: 50%

100% MRK50/50100% CNDCF

Portfolio after 10yr

$1283194.33M

Annual income

$1,264,463,955,290.81/yr

Blended yield

98.54%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CNDCF

No analyst data

Altman Z

2.4

Piotroski

3/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CNDCF buys

MRK buys

No recent congressional trades found for CNDCF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCNDCFMRK

Forward yield	12.97% ✓	3.25%
Annual dividend / share	$1.25	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	100% ✓	8.2%
Portfolio after 10y	$2566388.63M ✓	$30.7K
Annual income after 10y	$2,528,927,909,631.32 ✓	$950.29
Total dividends collected	$2563873.10M ✓	$6.1K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: CNDCF vs MRK ($10,000, DRIP)

Year	CNDCF Portfolio	CNDCF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$13,294	$2,593.75	$11,192	$351.54	+$2.1K → CNDCF
2	$20,669	$6,444.98	$12,524	$392.70	+$8.1K → CNDCF
3	$40,847	$18,730.37	$14,015	$438.65	+$26.8K → CNDCF
4	$112,892	$69,186.56	$15,682	$489.96	+$97.2K → CNDCF
5	$478,214	$357,418.82	$17,547	$547.23	+$460.7K → CNDCF
6	$3,341,654	$2,829,965.51	$19,632	$611.16	+$3.32M → CNDCF
7	$40,538,544	$36,962,974.51	$21,963	$682.53	+$40.52M → CNDCF
8	$881,522,462	$838,146,219.26	$24,571	$762.18	+$881.50M → CNDCF
9	$35,010,021,182	$34,066,792,148.22	$27,486	$851.08	+$35009.99M → CNDCF
10	$2,566,388,632,296	$2,528,927,909,631.32	$30,745	$950.29	+$2566388.60M → CNDCF

CNDCF vs MRK: Complete Analysis 2026

CNDCF — Stock

Canadian Banc Corp. is a close-ended equity mutual fund launched by Quadravest Inc. The fund is managed by Quadravest Capital Management Inc. It invests in the public equity markets of Canada. The fund invests in stocks of companies engaged in the banking sector. It benchmarks the performance of its portfolio against the S&P TSX Financial Index. The fund was formerly known as Canadian Banc Recovery Corp. Canadian Banc Corp. was formed on May 25, 2005 and is domiciled in Canada.

Full CNDCF Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this CNDCF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CNDCF vs SCHD CNDCF vs JEPI CNDCF vs O CNDCF vs KO CNDCF vs MAIN CNDCF vs JNJ CNDCF vs ABBV CNDCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.